Purple Pen Podcast

Dan and Jane are joined by Kristin Michaels, SHPA CEO and Professor Michael Dooley, SHPA President to discuss the proposed changes to the constitution and respond to members frequently asked questions.

Jane visited TAPNA 2017, the scientific meeting of the Toxicology and Poisons Network of Australasia. She spoke to Dr Kent Olson, keynote speaker and Medical Director of the San Francisco Division of the California Poison Control System. Also joining the discussion are two TAPNA attendees: Andrew Harding, Senior Emergency Department Pharmacist at Austin Health and Brett Anderson, Pharmacy Resident at Austin Health. We talk about: controversies in toxicology and their relevance to pharmacists: charcoal, digoxin-specific antibody and antivenoms emerging trends in illicit and prescription medicine abuse new models for accessing information about poisons and medicines

In the 20th episode of the podcast Jane and Dan continue their chat with Dr Rochelle Gellatly. Rochelle is a clinical pharmacy specialist in critical care, an Australian Advanced Practice Pharmacist in Cardiology and a Board Certified Pharmacotherapy Specialist with added qualifications in Cardiology. We talk to Rochelle about: the viscious cycle of heart failure (you might need to take notes) the different types of heart failure: HFrEF and HFpEF the newer agents for heart failure: sacubitril and ivabradine

Heather Cleland, Director of the Victorian Adult Burns Unit at The Alfred join Jane and Dan to discuss the work of the Unit, the management of major burns and medication usage in this special population

Jane and Dan are joined by Lisa Pont, SHPA Federal Councillor and chair of the National Translational Research Collaborative to discuss how to get your research started, done and published. Lisa also talks about how she is eagerly awaiting her copy of SHPA's new journal "Pharmacy Growth, Research, Innovation and Training - GRIT"

Jane and Dan speak to Emma Dean, smoking cessation co-ordinator at Alfred Health. We talk to Emma about: The optimal time to start a conversation about smoking cessation The ideal regimen and dosing for nicotine replacement therapy Whether e-cigarettes are a helpful alternative to conventional cigarettes The current thinking about varenicline and neuropsychiatric adverse effects

Jane and Dan talk to Professor Tina Brock, Human of Pharmacy and Professor of Pharmacy Education and Practice at Monash University. We talk to Tina about: Her journey from Mississippi to Melbourne What inter-professional learning means in practice What goes wrong in inter-professional collaboration and how we can be better at it Opportunities in automation and disruption What your online avatar says about you

Jane and Dan chat to Dr Rochelle Gellatly, a clinical pharmacy specialist in critical care, an Australian Advanced Practice Pharmacist in Cardiology and a Board Certified Pharmacotherapy Specialist with added qualifications in Cardiology. She is currently working in Vancouver. We talk to Rochelle about: Recent changes in thinking about hyperlipidaemia, target LDLs and risk assessment How scores for cardiovascular risk are used in practice What we know (or don't) about the optimal dose of a statin and the frequency of adverse events

Jane and Dan speak to Professor Geoff Isbister is a clinical toxicologist and Director of Clinical Toxicology at the University of Newcastle. We talk to Geoff about: The spectrum of clinical presentations of serotonin toxicity Significant drug interactions with SSRIs: tramadol or linezolid? Current trends in pharmaceutical overdose Whether antivenoms are useful (and a shout out to our overseas listeners)

In this special midweek episode, Dan is joined by NAPSA president Shefali Parekh from Congress in Perth. Dan and Shefali chat about NAPSA and the Congress, as well as several topical issues, including codeine up-scheduling, pharmacy student numbers, advanced practice and student placements in hospitals.